Babio is a high-tech enterprise specializing in the research, development, production and sales of in vitro diagnostic reagents. The company was successfully listed on the NEEQ on May 30, 2014 (stock name: Babio, stock code: 830774), becoming the first domestic in vitro diagnostic reagent listed company after the expansion of the NEEQ. The company has established a strict quality management system and passed the ISO9001:2008 and ISO13485:2003 international quality system certification.